Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Toshihiko Doi Takayuki Yoshino |
| Publication date | November 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |